WHO ICTRP trial
Development of a Treatment Pathway for Patients with Bladder Cancer and Coronary…
ChiCTR2500112231 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500112231 |
|---|---|
| Public title | Development of a Treatment Pathway for Patients with Bladder Cancer and Coronary Artery Disease Undergoing Transurethral Resection of Bladder Tumor: A Multicenter, Prospective, Real-World Cohort Study |
| Scientific title | Development of a Treatment Pathway for Patients with Bladder Cancer and Coronary Artery Disease Undergoing Transurethral Resection of Bladder Tumor: A Multicenter, Prospective, Real-World Cohort Study |
| Primary sponsor | Beijing Anzhen Hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Bladder Cancer and Coronary Artery Disease |
| Interventions | Priority TURBT Group:None;Priority Coronary Revascularization Group:None;group undergoing simultaneous TURBT and coronary artery revascularization:None;Natural group:None |
| Registration date | Nov 11, 2025 |
| Target size | Priority TURBT Group:140;Priority Coronary Revascularization Group:140;group… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: